Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Contact Us Sitemap Sign In Register
Link to Homepage About AHAF
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research


Sign up for Email Notifications
If you would like to be notified when submission deadlines are announced please click on the link below.

Sign up for new RFP announcements and submission deadline notifications.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research funding through the American Health Assistance Foundation (www.ahaf.org). Please follow instructions on the notification emails for removal requests.
 
AHAF Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research
 

  

Alzheimer's Disease Research - Current Award

Dr. Pritam Das

Pritam Das, Ph.D.

Mayo Clinic Jacksonville
Jacksonville, FL

Title: Cytokine Modulation Of Amyloid Beta Associated Pathologies In APP Mouse Models Of Alzheimer's Disease
Non-Technical Title: Effect Of Inflammation In The Brain On Disease Progression In Alzheimer’s Disease

Duration: April 1, 2009 - March 31, 2012
Award Type: Standard
Award Amount: $399,999


Summary:

The experiments proposed here will establish an experimental template to study potential disease modifiers, their roles in modulating Alzheimer’s disease (AD) like pathologies and their use in the future design of potential AD therapeutics.

Details:

Alzheimer's disease (AD) and other related dementia are accompanied by changes in inflammatory markers (cytokines) in the brain. This study will observe how over-expression of specific cytokines affects amyloid beta deposition in an AD mouse model. We hypothesize that immune modulating mediators, like cytokines, play both protective and harmful roles and will help us investigate their role in promoting or reducing amyloid beta associated pathologies in AD. In addition to gaining insight into the cytokines' roles in altering the pathology, these studies may provide the rationale for development of novel therapeutic approaches for the treatment of AD.